Literature DB >> 32154977

Integrated analysis of transcriptome, methylome and copy number aberrations data of marginal zone lymphoma and follicular lymphoma in dog.

Diana Giannuzzi1, Luca Giudice2, Laura Marconato3, Serena Ferraresso1, Rosalba Giugno2, Francesco Bertoni4, Luca Aresu5.   

Abstract

Marginal zone lymphoma (MZL) and follicular lymphoma (FL) are classified as indolent B-cell lymphomas in dogs. Aside from the clinical and histopathological similarities with the human counterpart, the molecular pathogenesis remains unclear. We integrated transcriptome, genome-wide DNA methylation and copy number aberration analysis to provide insights on the pathogenesis of canine MZL (n = 5) and FL (n = 7), also comparing them with diffuse large B-cell lymphoma (DLBCL). Transcriptome profiling highlighted the presence of similar biological processes affecting both histotypes, including BCR and TLR signalling pathways. However, FLs showed an enrichment of E2F targets, whereas MZLs were characterized by MYC-driven transcriptional activation signatures. FLs showed a distinctive loss on chr1 containing CEACAM23 and 24, conversely MZLs presented multiple recurrent gains on chr13, where MYC is located. The distribution of methylation peaks was similar between the two histotypes. Integrating data from the three omics, FLs resulted clearly separated from MZLs and DLBCL dataset. MZLs showed the enrichment of FoxM1 network and TLR associated TICAM1-dependent IRFs activation pathway. However, no specific signatures differentiated MZLs from DLBCLs. In conclusion, our study presents the first comprehensive analysis of molecular and epigenetic pathogenesis of canine FL and MZL.
© 2020 John Wiley & Sons Ltd.

Entities:  

Keywords:  Toll-like receptors; animal model; dog; indolent lymphoma; transcriptomic

Year:  2020        PMID: 32154977     DOI: 10.1111/vco.12588

Source DB:  PubMed          Journal:  Vet Comp Oncol        ISSN: 1476-5810            Impact factor:   2.613


  4 in total

1.  Hypermethylation-Mediated Silencing of CIDEA, MAL and PCDH17 Tumour Suppressor Genes in Canine DLBCL: From Multi-Omics Analyses to Mechanistic Studies.

Authors:  Eleonora Zorzan; Ramy Elgendy; Giorgia Guerra; Silvia Da Ros; Maria Elena Gelain; Federico Bonsembiante; Giulia Garaffo; Nicoletta Vitale; Roberto Piva; Laura Marconato; Luca Aresu; Mauro Dacasto; Mery Giantin
Journal:  Int J Mol Sci       Date:  2022-04-05       Impact factor: 5.923

2.  Phenotypical Characterization and Clinical Outcome of Canine Burkitt-Like Lymphoma.

Authors:  Luca Aresu; Chiara Agnoli; Arturo Nicoletti; Antonella Fanelli; Valeria Martini; Francesco Bertoni; Laura Marconato
Journal:  Front Vet Sci       Date:  2021-03-17

Review 3.  Bite-size introduction to canine hematologic malignancies.

Authors:  Matthew J Atherton; Nicola J Mason
Journal:  Blood Adv       Date:  2022-07-12

4.  Genomic and Transcriptomic Characterization of Canine Osteosarcoma Cell Lines: A Valuable Resource in Translational Medicine.

Authors:  Cecilia Gola; Diana Giannuzzi; Andrea Rinaldi; Selina Iussich; Paola Modesto; Emanuela Morello; Paolo Buracco; Luca Aresu; Raffaella De Maria
Journal:  Front Vet Sci       Date:  2021-05-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.